Literature DB >> 28319098

IRAP+ endosomes restrict TLR9 activation and signaling.

Joel Babdor1,2,3, Delphyne Descamps1,2,3,4, Aimé Cézaire Adiko5,6, Mira Tohmé1,2,3,7, Sophia Maschalidi1,2,3,8, Irini Evnouchidou5,6, Luiz Ricardo Vasconcellos1,2,3,9, Mariacristina De Luca5,6, Francois-Xavier Mauvais1,2,3, Meriem Garfa-Traore1,2,3, Melanie M Brinkmann10, Michel Chignard11,12, Bénédicte Manoury1,2,3, Loredana Saveanu5,6.   

Abstract

The retention of intracellular Toll-like receptors (TLRs) in the endoplasmic reticulum prevents their activation under basal conditions. TLR9 is activated by sensing ligands in specific endosomal-lysosomal compartments. Here we identified IRAP+ endosomes as major cellular compartments for the early steps of TLR9 activation in dendritic cells (DCs). Both TLR9 and its ligand, the dinucleotide CpG, were present as cargo in IRAP+ endosomes. In the absence of the aminopeptidase IRAP, the trafficking of CpG and TLR9 to lysosomes and signaling via TLR9 were enhanced in DCs and in mice following bacterial infection. IRAP stabilized CpG-containing endosomes by interacting with the actin-nucleation factor FHOD4, which slowed the trafficking of TLR9 toward lysosomes. Thus, endosomal retention of TLR9 via the interaction of IRAP with the actin cytoskeleton is a mechanism that prevents hyper-activation of TLR9 in DCs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319098     DOI: 10.1038/ni.3711

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  47 in total

Review 1.  Cdc42--the centre of polarity.

Authors:  Sandrine Etienne-Manneville
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

2.  The Formin family protein, formin homolog overexpressed in spleen, interacts with the insulin-responsive aminopeptidase and profilin IIa.

Authors:  Hideaki Tojo; Isao Kaieda; Harumi Hattori; Nozomi Katayama; Koji Yoshimura; Shigeya Kakimoto; Yukio Fujisawa; Eleonora Presman; Cydney C Brooks; Paul F Pilch
Journal:  Mol Endocrinol       Date:  2003-04-03

3.  Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.

Authors:  V L Gonçalves de Moraes; M Singer; B B Vargaftig; M Chignard
Journal:  Br J Pharmacol       Date:  1998-02       Impact factor: 8.739

4.  Vimentin binds IRAP and is involved in GLUT4 vesicle trafficking.

Authors:  Yohko Hirata; Toshio Hosaka; Takeo Iwata; Chung T K Le; Bayasgalan Jambaldorj; Kiyoshi Teshigawara; Nagakatsu Harada; Hiroshi Sakaue; Tohru Sakai; Katsuhiko Yoshimoto; Yutaka Nakaya
Journal:  Biochem Biophys Res Commun       Date:  2011-01-07       Impact factor: 3.575

5.  Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.

Authors:  Chaofeng Han; Jing Jin; Sheng Xu; Haibo Liu; Nan Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-07-18       Impact factor: 25.606

6.  IRAP identifies an endosomal compartment required for MHC class I cross-presentation.

Authors:  Loredana Saveanu; Oliver Carroll; Mirjana Weimershaus; Pierre Guermonprez; Elke Firat; Vivian Lindo; Fiona Greer; Jean Davoust; Roland Kratzer; Susanna R Keller; Gabriele Niedermann; Peter van Endert
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

7.  Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.

Authors:  Boyoun Park; Melanie M Brinkmann; Eric Spooner; Clarissa C Lee; You-Me Kim; Hidde L Ploegh
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

9.  Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.

Authors:  Francesca Prete; Marco Catucci; Mayrel Labrada; Stefania Gobessi; Maria Carmina Castiello; Elisa Bonomi; Alessandro Aiuti; William Vermi; Caterina Cancrini; Ayse Metin; Sophie Hambleton; Robbert Bredius; Luigi Daniele Notarangelo; Mirjam van der Burg; Ulrich Kalinke; Anna Villa; Federica Benvenuti
Journal:  J Exp Med       Date:  2013-01-21       Impact factor: 14.307

10.  Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection.

Authors:  Fatima Benmohamed; Mathieu Medina; Yong-Zheng Wu; Sophia Maschalidi; Gregory Jouvion; Laurent Guillemot; Michel Chignard; Bénédicte Manoury; Lhousseine Touqui
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  14 in total

1.  TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression.

Authors:  Haiju Zhang; Yi Caudle; Clay Wheeler; Yu Zhou; Charles Stuart; Baozhen Yao; Deling Yin
Journal:  J Neuroimmunol       Date:  2017-11-08       Impact factor: 3.478

2.  The GTPase Rab39a promotes phagosome maturation into MHC-I antigen-presenting compartments.

Authors:  Freidrich M Cruz; Jeff D Colbert; Kenneth L Rock
Journal:  EMBO J       Date:  2019-12-10       Impact factor: 11.598

3.  CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine.

Authors:  Wenting Lu; Cuiyun Cui; Yangyang Wang; Xiaomeng Sun; Shengnan Wang; Ming Yang; Yongli Yu; Liying Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-05       Impact factor: 4.813

4.  CD82 controls CpG-dependent TLR9 signaling.

Authors:  Nida S Khan; Daniel P Lukason; Marianela Feliu; Rebecca A Ward; Allison K Lord; Jennifer L Reedy; Zaida G Ramirez-Ortiz; Jenny M Tam; Pia V Kasperkovitz; Paige E Negoro; Tammy D Vyas; Shuying Xu; Melanie M Brinkmann; Mridu Acharaya; Katerina Artavanis-Tsakonas; Eva-Maria Frickel; Christine E Becker; Zeina Dagher; You-Me Kim; Eicke Latz; Hidde L Ploegh; Michael K Mansour; Cindy K Miranti; Stuart M Levitz; Jatin M Vyas
Journal:  FASEB J       Date:  2019-08-13       Impact factor: 5.191

Review 5.  Self-DNA Sensing by cGAS-STING and TLR9 in Autoimmunity: Is the Cytoskeleton in Control?

Authors:  Roberto Amadio; Giulia Maria Piperno; Federica Benvenuti
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

6.  Control of IFN-I responses by the aminopeptidase IRAP in neonatal C57BL/6 alveolar macrophages during RSV infection.

Authors:  Carole Drajac; Daphné Laubreton; Quentin Marquant; Claire Chottin; Cécile Ferret; Edwige Bouguyon; Isabelle Schwartz-Cornil; Loredana Saveanu; Sabine Riffault; Delphyne Descamps
Journal:  Mucosal Immunol       Date:  2021-04-12       Impact factor: 7.313

7.  STIM1 promotes migration, phagosomal maturation and antigen cross-presentation in dendritic cells.

Authors:  Paula Nunes-Hasler; Sophia Maschalidi; Carla Lippens; Cyril Castelbou; Samuel Bouvet; Daniele Guido; Flavien Bermont; Esen Y Bassoy; Nicolas Page; Doron Merkler; Stéphanie Hugues; Denis Martinvalet; Bénédicte Manoury; Nicolas Demaurex
Journal:  Nat Commun       Date:  2017-11-24       Impact factor: 14.919

Review 8.  Below the surface: The inner lives of TLR4 and TLR9.

Authors:  Laura Marongiu; Laura Gornati; Irene Artuso; Ivan Zanoni; Francesca Granucci
Journal:  J Leukoc Biol       Date:  2019-03-22       Impact factor: 4.962

9.  IRAP-dependent endosomal T cell receptor signalling is essential for T cell responses.

Authors:  Irini Evnouchidou; Pascal Chappert; Samira Benadda; Andres Zucchetti; Mirjana Weimershaus; Marcelle Bens; Vivien Caillens; Despoina Koumantou; Sophie Lotersztajn; Peter van Endert; Jean Davoust; Pierre Guermonprez; Claire Hivroz; David A Gross; Loredana Saveanu
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

Review 10.  Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.

Authors:  Sebastian Montealegre; Peter M van Endert
Journal:  Front Immunol       Date:  2019-01-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.